StockTipsArenaBeta

BUY Ajanta Pharma Limited — Aastha Jain, Hem Securities

BUYAjanta Pharma Limited

byAastha Jain, Hem SecuritiesHorizon: BTST13 Aug 2026, 9:36 am ISTvia Zee Business (Live)

Entry₹3,650Inferred
Target₹3,760
Total upside +3.01% (call closed)
Stop loss₹3,539-3.04% risk
At expiry₹3,68014 Aug 2026, 3:20 pm
Expired+0.82%
Follow Aastha Jain for new calls(19% target hit, 42 closed calls)Get alertsWatch AJANTPHARM for new buy/sell callsGet alertsSee 6 active BTST picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 14 Aug 2026
2 supporting0 opposing
Supports the BUY call (2)

Ajanta Pharma Shares Rise 2% as Q1 Profit Reaches Rs 334 Crore

NewsGoogle News·14 Aug · today

(opens in new tab)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·14 Aug · today

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.